Publications by authors named "Sara Fancelli"

Claim this Profile
T
Transcriptomic analysis on pancreatic adenocarcinoma patients uncovers KRAS-mediated PPAR pathway alteration.
Giuseppe Defazio, Federico Scolari, Sara Fancelli, Simone Polvani, Daniele Lavacchi

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC.
Alessandro Tubita, Sara Fancelli, Lorenzo Anela, Giulia Petroni, Enrico Caliman

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender Matters. Sex-related Differences in Immunotherapy Outcome in Patients with Non-small Cell Lung Cancer.
Enrico Caliman, Maria Cristina Petrella, Virginia Rossi, Francesca Mazzoni, Anna Maria Grosso, Sara Fancelli

Curr Cancer Drug Targets· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological complete response achieved with FLOT chemotherapy in two patients with MSI-H esophagogastric junction and gastric adenocarcinoma.
Federica Cosso, Daniele Lavacchi, Luca Messerini, Vittorio Briganti, Francesca Castiglione, Sara Fancelli

Anticancer Drugs· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic signatures of and expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapy.
Enrico Caliman, Sara Fancelli, Federico Scolari, Adriano Pasqui, Clara Manneschi

Oncol Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors.
Martina Catalano, Sara Fancelli, Enrico Caliman, Francesca Mazzoni, Marta Gatta Michelet

Sci Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unconventional strategy could be the future: From target to KRAS broad range treatment.
Sara Fancelli, Giulia Petroni, Serena Pillozzi, Lorenzo Antonuzzo

Heliyon· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.
Luca Cantini, Francesco Paoloni, Federica Pecci, Francesco Spagnolo, Carlo Genova, Sara Fancelli

J Natl Cancer Inst· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid Biopsy and Non-small-cell Lung Cancer: Expecting More Fluid Management of Patients.
Sara Fancelli, Giandomenico Roviello, Francesca Castiglione, Enrico Caliman, Mazzoni Francesca

Curr Pharm Biotechnol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer.
Federica Cosso, Daniele Lavacchi, Sara Fancelli, Enrico Caliman, Marco Brugia

Anticancer Drugs· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing.
Daniele Lavacchi, Sara Fancelli, Eleonora Buttitta, Gianmarco Vannini, Alessia Guidolin

Int J Mol Sci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification.
Enrico Caliman, Sara Fancelli, Giulia Petroni, Marta Rita Gatta Michelet, Federica Cosso

Lung Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population.
Sara Fancelli, Enrico Caliman, Francesca Mazzoni, Luca Paglialunga, Marta Rita Gatta Michelet

Front Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer.
Daniele Lavacchi, Sara Fancelli, Giandomenico Roviello, Francesca Castiglione, Enrico Caliman

Front Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions.
Daniele Lavacchi, Enrico Caliman, Gemma Rossi, Eleonora Buttitta, Cristina Botteri, Sara Fancelli

Pharmacol Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy.
Enrico Caliman, Sara Fancelli, Carlotta Ottanelli, Francesca Mazzoni, Luca Paglialunga

Cancer Treat Res Commun· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma.
Adriano Pasqui, Anna Boddi, Domenico Andrea Campanacci, Guido Scoccianti, Andrea Bernini, Sara Fancelli

Int J Mol Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment.
Elisabetta Gambale, Sara Fancelli, Enrico Caliman, Maria Cristina Petrella, Laura Doni

J Immunother Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of the observational prospective RealFLOT study.
Elisa Giommoni, Daniele Lavacchi, Giuseppe Tirino, Lorenzo Fornaro, Francesco Iachetta, Sara Fancelli

BMC Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study.
Agnese Paderi, Sara Fancelli, Enrico Caliman, Serena Pillozzi, Elisabetta Gambale

Curr Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM).
Maria Gonzalez-Cao, Teresa Puertolas, Mar Riveiro, Eva Muñoz-Couselo, Carolina Ortiz, Sara Fancelli

J Immunother Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chasing the Target: New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer. Updated Evidence and Future Perspectives.
Sara Fancelli, Enrico Caliman, Francesca Mazzoni, Marco Brugia, Francesca Castiglione

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proprotein convertase furin in SARS-CoV-2 and non-small cell lung cancer.
Rafael Rosell, Niki Karachaliou, Sara Fancelli, Oscar Arrieta, Giancarlo Troncone

Transl Lung Cancer Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies.
Mariacarmela Santarpia, Andrés Aguilar, Imane Chaib, Andrés Felipe Cardona, Sara Fancelli

Cancers (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment.
Giandomenico Roviello, Andrea Casadei-Gardini, Stefania Nobili, Enrico Mini, Sara Fancelli

J Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis